These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20131425)

  • 21. Long term evaluation of etiological treatment of chagas disease with benznidazole.
    Cancado JR
    Rev Inst Med Trop Sao Paulo; 2002; 44(1):29-37. PubMed ID: 11896410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Longitudinal study of the persistence of the therapeutic action of nifurtimox and benznidazole in patients with chronic chagas infection].
    Schenone H; Rojas A; Alfaro E; Concha L; Aranda R
    Bol Chil Parasitol; 1981; 36(3-4):59-62. PubMed ID: 6812600
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chagas disease].
    Develoux M; Lescure FX; Le Loup G; Pialoux G
    Rev Med Interne; 2009 Aug; 30(8):686-95. PubMed ID: 19201068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
    Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
    Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
    [No Abstract]   [Full Text] [Related]  

  • 25. Trypanosoma cruzi meningoencephalitis in a patient with acquired immunodeficiency syndrome.
    Yasukawa K; Patel SM; Flash CA; Stager CE; Goodman JC; Woc-Colburn L
    Am J Trop Med Hyg; 2014 Jul; 91(1):84-5. PubMed ID: 24891470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS.
    Sartori AM; Ibrahim KY; Nunes Westphalen EV; Braz LM; Oliveira OC; Gakiya E; Lopes MH; Shikanai-Yasuda MA
    Ann Trop Med Parasitol; 2007 Jan; 101(1):31-50. PubMed ID: 17244408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.
    Garcia-Bournissen F; Altcheh J; Giglio N; Mastrantonio G; Della Védova CO; Koren G
    Paediatr Drugs; 2009; 11(1):33-7. PubMed ID: 19127950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update in treatment of Chagas disease.
    Le Loup G; Pialoux G; Lescure FX
    Curr Opin Infect Dis; 2011 Oct; 24(5):428-34. PubMed ID: 21857512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppression and Chagas disease: a management challenge.
    Pinazo MJ; Espinosa G; Cortes-Lletget C; Posada Ede J; Aldasoro E; Oliveira I; Muñoz J; Gállego M; Gascon J
    PLoS Negl Trop Dis; 2013; 7(1):e1965. PubMed ID: 23349998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chagas disease: clinical overview and implications for nursing.
    Lennox HA; Karcz DA; Tales H; El Masri M
    Medsurg Nurs; 2007 Aug; 16(4):229-35; quiz 236. PubMed ID: 17907695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.
    Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA
    Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
    Moya PR; Trombotto GT
    Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole].
    Ferreira Hde O
    Rev Soc Bras Med Trop; 1990; 23(4):209-11. PubMed ID: 2133586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Trypanosoma cruzi coinfection in HIV-positive individuals outside endemic areas.
    Pérez-Molina JA
    Curr Opin Infect Dis; 2014 Feb; 27(1):9-15. PubMed ID: 24275694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance and safety of nifurtimox in patients with chronic chagas disease.
    Jackson Y; Alirol E; Getaz L; Wolff H; Combescure C; Chappuis F
    Clin Infect Dis; 2010 Nov; 51(10):e69-75. PubMed ID: 20932171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chagas seropositive donors in kidney transplantation.
    Sousa AA; Lobo MC; Barbosa RA; Bello V
    Transplant Proc; 2004 May; 36(4):868-9. PubMed ID: 15194296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection].
    Rev Soc Bras Med Trop; 2006; 39(4):392-415. PubMed ID: 17119760
    [No Abstract]   [Full Text] [Related]  

  • 39. Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient.
    Jardim E; Takayanagui OM
    J Trop Med Hyg; 1994 Dec; 97(6):367-70. PubMed ID: 7966540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Benznidazole and chronic Chagas disease].
    Manigot DA
    Medicina (B Aires); 1984; 44(1):105-6. PubMed ID: 6443011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.